Clinical trial of effects of liposomal hyaluronic acid against vulvo-vaginal dryness

Efficacy of a medical device containing liposomal hyaluronic acid against vulvo-vaginal dryness

Article Specifications

This clinical trial was published in 2015 in French  journal of Gynécologie Obstétrique & Fertilité by french gynecologists. The goal of this Clinical Study is to evaluate the efficacy of a medical device containing liposomal HA upon patients of different ages suffering from vulvo-vaginal dryness (VVD). Tested product Mucogyne was applied 3 times a week for 84 days by 47 patients, 28 premenopausal young women (mean age: 32 years old) and 19 post-menopausal women (mean age: 57.5 years old) all suffering from VVD associated to spontaneous pain and dyspareunia. Clinical evaluations and Vaginal Health Index (VHS) were calculated at 0, 1 and 3 months.

Results

Liposomal AH significantly decreases symptoms and clinical signs of VVD at all ages and represents a safe and efficient alternative to topical and/or systemic hormonal therapy after menopause.